Extended letermovir administration, beyond day 100, is effective for CMV prophylaxis in patients with graft versus host disease

Post time 2024-6-17 14:51:37

journal：Transplant Infectious Disease

Authors：Rajat Bansal; Christian A Gordillo; Rachel Abramova; Amer Assal; Markus Y Mapara; Marcus R Pereira; Ran Reshef

Published date：2021-4-

DOI：10.1111/tid.13487

PDF link：https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/tid.13487

Article link：http://dx.doi.org/10.1111/tid.13487

Article Source：Wiley。

Remark：

Post time 2024-6-17 14:51:38

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2024-6-17 14:51:58

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Wiley] Extended letermovir administration, beyond day 100, is effective for CMV prophylaxis in patients with graft versus host disease

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today